National Health (Weighted average disclosed price – April 2022 reduction day) Amendment Determination 2022 (Cth)
PB 20 of 2022
National Health (Weighted average disclosed price – April 2022 reduction day) Amendment Determination 2022
I, ADRIANA PLATONA, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care, make this determination under subsection 99ADB(4) of the National Health Act 1953.
Dated: 24 February 2022
ADRIANA PLATONA
First Assistant Secretary
Technology Assessment and Access Division
Department of Health
1 Name of Instrument
(1) This instrument is the National Health (Weighted average disclosed price – April 2022 reduction day) Amendment Determination 2022.
(2) This instrument may also be cited as PB 20 of 2022.
2 Commencement
This instrument commences on the day after it is registered.
3 Authority
This instrument is made under subsection 99ADB(4) of the National Health Act 1953.
4 Amendments to PB 134 of 2021
Schedule 1 amends the National Health (Weighted average disclosed price – April 2022 reduction day) Determination 2021 (PB 134 of 2021).
Schedule 1 Amendments
[1] Schedule 1
after:
| 28 | Buprenorphine | Transdermal patch 5 mg | Transdermal | Norspan | $9.60 |
omit:
| 29 | Cabazitaxel | Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent | Injection | Cabazitaxel Juno | $595.32 |
| 30 | Cabazitaxel | Concentrated injection 60 mg (as acetone solvate) in 1.5 mL, with diluent | Injection | Jevtana | $595.32 |
| 31 | Cabazitaxel | Solution concentrate for I.V. infusion 60 mg in 6 mL | Injection | Cabazitaxel Ever Pharma | $595.32 |
substitute:
| 29 | Cabazitaxel | Concentrated injection 60 mg in 1.5 mL, with diluent | Injection | Cabazitaxel Juno | $595.32 |
| 30 | Cabazitaxel | Concentrated injection 60 mg in 1.5 mL, with diluent | Injection | Jevtana | $595.32 |
| 31 | Cabazitaxel | Solution concentrate for I.V. infusion 60 mg in 6 mL | Injection | Cabazitaxel Ever Pharma | $595.32 |
| 31A | Cabazitaxel | Concentrated injection 60 mg in 1.5 mL, with diluent | Injection | MSN Cabazitaxel | $595.32 |
[2] Schedule 1
after:
| 52 | Fluorouracil | Injection 5000 mg in 100 mL | Injection | Fluorouracil Ebewe | $24.22 |
omit:
| 53 | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 250/50 | $30.18 |
| 54 | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 250/50 | $30.18 |
| 55 | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 500/50 | $40.86 |
| 56 | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 500/50 | $40.86 |
| 57 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | $30.18 |
| 58 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 125/25 | $30.18 |
| 59 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | $30.18 |
| 60 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 125/25 | $30.18 |
| 61 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 125/25 | $30.18 |
| 62 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seroflo 125/25 | $30.18 |
| 63 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | $40.86 |
| 64 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 250/25 | $40.86 |
| 65 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | $40.86 |
| 66 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 250/25 | $40.86 |
| 67 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 250/25 | $40.86 |
| 68 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seroflo 250/25 | $40.86 |
[3] Schedule 2
after:
| 1313 | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 100/50 | $28.34 |
insert:
| 1313 A | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 250/50 | $30.18 |
| 1313 B | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 250/50 | $30.18 |
| 1313 C | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 500/50 | $40.86 |
| 1313 D | Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 500/50 | $40.86 |
[4] Schedule 2
after:
| 1315 | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 50/25 | $28.34 |
insert:
| 1315 A | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | $30.18 |
| 1315 B | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 125/25 | $30.18 |
| 1315 C | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | $30.18 |
| 1315 D | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 125/25 | $30.18 |
| 1315 E | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 125/25 | $30.18 |
| 1315 F | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seroflo 125/25 | $30.18 |
| 1315 G | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | $40.86 |
| 1315 H | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 250/25 | $40.86 |
| 1315 I | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | $40.86 |
| 1315 J | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 250/25 | $40.86 |
| 1315 K | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 250/25 | $40.86 |
| 1315 L | Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seroflo 250/25 | $40.86 |
[5] Schedule 2
after:
| 680 | Chorionic gonadotrophin | Injection set containing powder for injection 1,500 units, 3 and solvent 1 mL, 3 | Injection | Pregnyl | $31.39 |
insert:
| 680A | Chorionic gonadotrophin | Injection set containing powder for injection 1,500 units, 3 and solvent 1 mL, 3 (s19A) | Injection | Brevactid 1500 I.E | $78.09 |
[6] Schedule 2
after:
| 681 | Chorionic gonadotrophin | Powder for injection 5,000 units with solvent | Injection | Pregnyl | $9.11 |
insert:
| 681A | Chorionic gonadotrophin | Powder for injection 5,000 units with solvent (s19A) | Injection | Choriomon 5000 I.E | $110.58 |
| 681B | Ciclosporin | Eye drops 1 mg per mL, single dose units 0.3 mL, 30 | Application to the Eye | Ikervis | $54.70 |
[7] Schedule 2
after:
| 1077 | Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Enbrel | $873.03 |
insert:
| 1077A | Etanercept | Injection 50 mg in 1 mL single use dose-dispenser cartridges, 4 | Injection | Enbrel | $873.03 |
[7] Schedule 2
after:
| 1882 | Levothyroxine | Tablet containing 100 micrograms anhydrous levothyroxine sodium | Oral | Oroxine | $14.20 |
insert:
| 1882A | Levothyroxine | Tablet containing 125 micrograms anhydrous levothyroxine sodium | Oral | Eltroxin | $12.49 |
0
0
0